Pliant Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Pliant Therapeutics using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $-0.43 | $-0.53 | 18.9 % |
| Q2 | 2025-08-07 | $-0.71 | $-0.65 | -9.23 % |
| Q1 | 2025-05-08 | $-0.92 | $-0.75 | -22.7 % |
| Q4 | 2025-03-03 | $-0.82 | $-0.98 | 16.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-08 | $0 | $333.33K | -100.0 % |
| Q4 | 2025-03-03 | $0 | $83.33K | -100.0 % |
| Q3 | 2024-11-07 | $0 | $530.00K | -100.0 % |
| Q1 | 2024-05-06 | $0 | $460.00K | -100.0 % |
Pliant Therapeutics (PLRX) is scheduled to report earnings on March 2, 2026. The last reported earnings were for reported on November 6, 2025 for Q3.
The Actual EPS was $-0.43, which beat the estimate of $-0.53.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.